These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19903449)

  • 41. Activation of CYP3A-mediated testosterone 6β-hydroxylation by tanshinone IIA and midazolam 1-hydroxylation by cryptotanshinone in human liver microsomes.
    Qiu F; Zhang R; Wang G; Gao C; Sun J; Jiang J; Ma Y
    Xenobiotica; 2010 Dec; 40(12):800-6. PubMed ID: 20964620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human cytochrome P450: metabolism of testosterone by CYP3A4 and inhibition by ketoconazole.
    Usmani KA; Tang J
    Curr Protoc Toxicol; 2004 Jun; Chapter 4():Unit4.13. PubMed ID: 20945304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influence of isoliensinine on activity of CYP3A in rats].
    Nan L; Xuan GD
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):178-82. PubMed ID: 22499515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain.
    Hagemeyer CE; Rosenbrock H; Ditter M; Knoth R; Volk B
    Neuroscience; 2003; 117(3):521-9. PubMed ID: 12617959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereoselective Oxidation Kinetics of Deoxycholate in Recombinant and Microsomal CYP3A Enzymes: Deoxycholate 19-Hydroxylation Is an In Vitro Marker of CYP3A7 Activity.
    Chen YJ; Zhang J; Zhu PP; Tan XW; Lin QH; Wang WX; Yin SS; Gao LZ; Su MM; Liu CX; Xu L; Jia W; Sevrioukova IF; Lan K
    Drug Metab Dispos; 2019 Jun; 47(6):574-581. PubMed ID: 30918015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toward basic understanding of the partition coefficient log P and its application in QSAR.
    Chuman H
    SAR QSAR Environ Res; 2008; 19(1-2):71-9. PubMed ID: 18311635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downregulation of hepatic cytochrome P450 3A in mice infected with Babesia microti.
    Shimamoto Y; Sasaki M; Ikadai H; Ishizuka M; Yokoyama N; Igarashi I; Hoshi F; Kitamura H
    J Vet Med Sci; 2012 Feb; 74(2):241-5. PubMed ID: 21959890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory effects of saturated and polyunsaturated fatty acids on the cytochrome P450 3A activity in rat liver microsomes.
    Hirunpanich V; Sethabouppha B; Sato H
    Biol Pharm Bull; 2007 Aug; 30(8):1586-8. PubMed ID: 17666827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice.
    Bromek E; Danek PJ; Wójcikowski J; Basińska-Ziobroń A; Pukło R; Solich J; Dziedzicka-Wasylewska M; Daniel WA
    Pharmacol Rep; 2022 Oct; 74(5):1107-1114. PubMed ID: 36018449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of CYP3A by morroniside in rats.
    Xiong S; Li J; Zhang W; Wang X; Zhang Z
    J Pharmacol Sci; 2015 Apr; 127(4):414-8. PubMed ID: 25953268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification, induction and localization of cytochrome P450s of the 3A-subfamily in mouse brain.
    Rosenbrock H; Hagemeyer CE; Ditter M; Knoth R; Volk B
    Neurotox Res; 2001 Aug; 3(4):339-49. PubMed ID: 14715464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative hydrolysis of scoparone by cytochrome p450 CYP2C29 reveals a novel metabolite.
    Meyer RP; Hagemeyer CE; Knoth R; Kurz G; Volk B
    Biochem Biophys Res Commun; 2001 Jul; 285(1):32-9. PubMed ID: 11437368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological effects of Byrsocarpus coccineus in vitro.
    Akindele AJ; Eksioglu EA; Kwan JC; Adeyemi OO; Liu C; Luesch H; James MO
    Pharm Biol; 2011 Feb; 49(2):152-60. PubMed ID: 21110733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel approach to study the activity and stoichiometry simultaneously for microsomal pentoxyresorufin-O-dealkylase reaction.
    Rastogi S; Das M; Khanna SK
    FEBS Lett; 2002 Feb; 512(1-3):121-4. PubMed ID: 11852064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chromatographic assays of drug oxidation by human cytochrome P450 3A4.
    Sohl CD; Cheng Q; Guengerich FP
    Nat Protoc; 2009; 4(9):1252-7. PubMed ID: 19661995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gender-dependent activity of CYP3A is indirectly modified by GR in the noradrenergic system.
    Kot M; Kreiner G; Chmielarz P; Kuśmierczyk J; Nalepa I; Daniel WA
    Pharmacol Rep; 2013; 65(5):1431-4. PubMed ID: 24399741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in expression of hepatic cytochrome P450 subfamily enzymes during development of adjuvant-induced arthritis in rats.
    Sanada H; Sekimoto M; Kamoshita A; Degawa M
    J Toxicol Sci; 2011 Apr; 36(2):181-90. PubMed ID: 21467745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circadian Cyp3a11 metabolism contributes to chronotoxicity of hypaconitine in mice.
    Lin Y; Zhou Z; Yang Z; Gao L; Wang S; Yu P; Wu B
    Chem Biol Interact; 2019 Aug; 308():288-293. PubMed ID: 31150629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A microtiter-plate-based cytochrome P450 3A activity assay in fish cell lines.
    Christen V; Oggier DM; Fent K
    Environ Toxicol Chem; 2009 Dec; 28(12):2632-8. PubMed ID: 19245271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does Crizotinib Auto-Inhibit CYP3A in vivo?
    Bland AR; Shrestha N; Rosengren RJ; Ashton JC
    Pharmacology; 2020; 105(11-12):715-718. PubMed ID: 32460299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.